文献速递腹部泌尿生殖US

1385个肾上腺肿块的超声表现:1319个良性及66个恶性肿块的回顾性研究

Ultrasonographic Findings of 1385 Adrenal Masses: A Retrospective Study of 1319 Benign and 66 Malignant Masses.
PubMed 文献 · J Ultrasound Med · 2017-12-01

该回顾性研究对1363例患者的1385个肾上腺病变行超声检查,评估大小、形态、边缘、回声、回声质地、囊性坏死、钙化及血供,并与病理诊断对照。66个(4.8%)恶性病变在大小、形态、边缘、回声质地及血供上与良性病变有显著差异(P < .01),不规则形态、边缘不清、回声质地不均及血供提示恶性,敏感度分别为45.5%、34.8%、92.4%、15.2%,特异度分别为97.0%、99.2%、97.3%、97.5%。结论认为超声可作为肾上腺肿瘤的有效辅助诊断工具。

要点

  • 恶性肾上腺病变平均6.3 ± 2.4 cm,良性4.6 ± 1.7 cm(P < .01)。
  • 回声质地不均预测恶性敏感度92.4%、特异度97.3%,为各征象中敏感度最高。
  • 形态不规则、边缘不清、血供预测恶性特异度均≥97.0%,但敏感度较低。

核心结论

  • 超声可作为肾上腺肿瘤的有效辅助诊断工具。
  • 肾上腺病变体积大、形态不规则、边缘不清、回声质地不均及有血供可能是恶性的有效指标。

研究设计与样本

  • 回顾性研究,对1363例患者的1385个肾上腺病变行超声检查,并与病理诊断对照。
  • 记录参数包括大小、形态、边缘、回声、回声质地、囊性坏死、钙化及血供,计算侵袭性征象预测恶性的敏感度与特异度。

关键影像表现/征象

  • 大多数肿瘤形态规则且呈低回声。
  • 66个(4.8%)恶性病变包括33个恶性嗜铬细胞瘤、20个肾上腺皮质癌、10个转移瘤、2个平滑肌肉瘤和1个原始神经外胚层肿瘤。
  • 1319个(95.2%)良性病变包括832个腺瘤、182个嗜铬细胞瘤、153个结节性肾上腺增生、54个髓脂肪瘤、42个囊肿、23个神经节神经瘤、10个神经鞘瘤、8个皮质肿瘤嗜酸性细胞、4个畸胎瘤、4个结核、4个原发性色素性结节性肾上腺皮质病和3个Castleman病。
  • 恶性病变显著大于良性病变(均值 ± 标准差,6.3 ± 2.4 cm vs 4.6 ± 1.7 cm;P < .01)。
  • 恶性与良性肿瘤在形态、边缘、回声质地和血供方面差异有统计学意义(P < .01)。

诊断标准与关键数值

  • 形态不规则预测恶性:敏感度45.5%,特异度97.0%。
  • 边缘不清预测恶性:敏感度34.8%,特异度99.2%。
  • 回声质地不均预测恶性:敏感度92.4%,特异度97.3%。
  • 有血供预测恶性:敏感度15.2%,特异度97.5%。

临床应用与阅片要点

  • 原文结论认为超声可作为肾上腺肿瘤的有效辅助诊断工具,体积大、形态不规则、边缘不清、回声质地不均及有血供可能是恶性的有效指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the features of adrenal masses on ultrasonography and correlate the findings with the pathologic diagnoses to help distinguish benign from malignant adrenal lesions.

METHODS: Ultrasonography was performed in 1363 patients with adrenal lesions. The following ultrasonographic parameters were recorded: size, shape, margin, echogenicity, echo texture, cystic necrosis, calcifications, and blood supply. The sensitivity and specificity of aggressive features for predicting malignancy were calculated.

RESULTS: Of 1385 adrenal lesions, 66 (4.8%) were malignant: 33 malignant pheochromocytomas, 20 adrenal cortical carcinomas, 10 metastases, 2 leiomyosarcomas, and 1 primitive neuroectodermal tumor. The remaining 1319 (95.2%) lesions were benign: 832 adenomas, 182 pheochromocytomas, 153 nodular adrenal hyperplasia, 54 myelolipomas, 42 cysts, 23 ganglioneuromas, 10 schwannomas, 8 cortical tumor eosinophils, 4 teratomas, 4 tuberculosis, 4 primary pigmented nodular adrenocortical disease, and 3 Castleman disease. Most of the tumors were regular and hypoechoic. The malignant lesions were significantly larger than the benign lesions (mean ± SD, 6.3 ± 2.4 versus 4.6 ± 1.7 cm; P < .01). Significant differences between malignant and benign tumors were observed when comparing the shape, margins, echo texture and vascularization of the analyzed lesions (P < .01). An irregular shape, poor definition of margins, heterogeneous echo texture, and vascularization indicated malignancy, with sensitivity and specificity of 45.5% and 97.0%, 34.8% and 99.2%, 92.4% and 97.3%, and 15.2% and 97.5%, respectively.

CONCLUSIONS: Ultrasonography could be an effective diagnostic supplementary tool for adrenal tumors. A large size, irregular shape, poorly defined margins, heterogeneous echo texture, and vascularization of adrenal lesions could be effective indicators of malignancy.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Gong X, Yu Y, Zhan W, et al. Ultrasonographic Findings of 1385 Adrenal Masses: A Retrospective Study of 1319 Benign and 66 Malignant Masses. J Ultrasound Med. 2017. PMID: 29194699. doi:10.1002/jum.14471

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。